MCX shares plunge 8% after Q4 results

MCX shares plummeted 8% to Rs 3,715 in Wednesday's intraday trade on BSE after the company released its quarterly report, which showed positive results but fell below market estimates for the quarter ending March 2024.

Shares of () plunged 8% to Rs 3,715 in Wednesday's intraday trade on BSE following the company's report of positive but below-estimate numbers for the quarter ended March 2024.

Its net profit for the January-March quarter of FY24 stood at Rs 87.8 crore, compared to Rs 5.4 crore in the same period of FY23.

Meanwhile, its operating revenue climbed 35% to Rs 181.14 crore in Q4 against Rs 133.75 crore in the March 2023 quarter. EBITDA came at Rs 120.33 crore in Q4 against Rs 22.15 crore in the corresponding quarter of the previous fiscal.

The MCX saw its margins expand sharply to 56.3% from 1.6% during the same period of the previous fiscal.

Also Read:

The company also declared a final dividend of Rs 7.64 per equity share for FY24.

The recommended dividend will be approved by the shareholders at the 22nd Annual General Meeting. The company is yet to announce the date of the AGM, record date and eligibility of shareholders.

At 11:01 am, the stock was trading 6% lower at Rs 3,787 on BSE. However, the stock has delivered significant returns to its investors, having rallied over 150% in the last one year and more than 170% in the past two years.

Also Read:

As per Trendlyne data, the average target price of the stock is Rs 3,570, which shows a downside potential of 5% from the current market prices. The consensus recommendation from 9 analysts for the stock is a 'Hold'.

In technical terms, the relative strength index (RSI) of the stock is currently at 67.6, signalling it's neither trading in the overbought nor the oversold territory. Additionally, the MACD is at 80.9, which is above its centre and signal line, this is a bullish indicator.

MCX stock stood higher than the 20-day, 30-day, 50-day, 100-day, 150-day and 200-day simple moving averages (SMAs), while lower than 5-day and 10-day SMAs.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)

Source: Stocks-Markets-Economic Times

Останні публікації
Dow Jones, Nasdaq, S&P 500 weekly preview: New economic data could boost stocks
23.09.2024 - 16:00
Ankam CEO Wen Lung Wang acquires $141k in company stock
23.09.2024 - 16:00
Biden proposes banning Chinese vehicles from US roads with software crackdown
23.09.2024 - 16:00
Why Barclays expects Tesla's third-quarter deliveries to top consensus estimates
23.09.2024 - 16:00
Palantir valuation leaves 'no room for error' - Raymond James
23.09.2024 - 16:00
Biohaven's genetic disease drug meets main trial goal
23.09.2024 - 16:00
White House to spell out plan to safeguard US auto sector, avoid second 'China shock'
23.09.2024 - 16:00
Hedge funds are using Fed's big rate move to buy US tech stocks says Goldman Sachs
23.09.2024 - 16:00
Tempur Sealy to divest more than 100 stores in bid to close $4 billion Mattress Firm deal
23.09.2024 - 16:00
Barclays sees muted demand for iPhone 16
23.09.2024 - 16:00
Consumer confidence, GDP, and Powell's speech headline busy economic week
23.09.2024 - 16:00
TSMC, Samsung discuss building chip factories in UAE: WSJ
23.09.2024 - 16:00
Retailer MINISO to buy nearly 30% stake in China's Yonghui for $893 million
23.09.2024 - 16:00
PodcastOne executive chairman buys $32,181 in company stock
23.09.2024 - 16:00
Is Super Micro (SMCI) a $1,000 stock? Wall Street analyst discusses
23.09.2024 - 16:00

© Analytic DC. All Rights Reserved.

new
Аналіз ринку Комплексний аналіз GBP/USD
Ласкаво просимо в чат підтримки!
*
*

Ваш запит успішно надіслано!
Скоро з вами зв′яжуться.